JBT MAREL CORP (JBTM) Fundamental Analysis & Valuation

NYSE:JBTM • US4778391049

Current stock price

129.64 USD
-5.63 (-4.16%)
At close:
129.64 USD
0 (0%)
After Hours:

This JBTM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. JBTM Profitability Analysis

1.1 Basic Checks

  • JBTM had positive earnings in the past year.
  • JBTM had a positive operating cash flow in the past year.
  • JBTM had positive earnings in 4 of the past 5 years.
  • JBTM had a positive operating cash flow in each of the past 5 years.
JBTM Yearly Net Income VS EBIT VS OCF VS FCFJBTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

1.2 Ratios

  • JBTM's Return On Assets of -0.62% is on the low side compared to the rest of the industry. JBTM is outperformed by 69.47% of its industry peers.
  • JBTM has a Return On Equity of -1.13%. This is in the lower half of the industry: JBTM underperforms 66.41% of its industry peers.
  • JBTM's Return On Invested Capital of 2.97% is on the low side compared to the rest of the industry. JBTM is outperformed by 64.12% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for JBTM is significantly below the industry average of 10.16%.
Industry RankSector Rank
ROA -0.62%
ROE -1.13%
ROIC 2.97%
ROA(3y)7.79%
ROA(5y)6.83%
ROE(3y)14.51%
ROE(5y)14.91%
ROIC(3y)4.56%
ROIC(5y)5.43%
JBTM Yearly ROA, ROE, ROICJBTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

1.3 Margins

  • JBTM has a Operating Margin (5.80%) which is in line with its industry peers.
  • JBTM's Operating Margin has declined in the last couple of years.
  • JBTM's Gross Margin of 35.15% is fine compared to the rest of the industry. JBTM outperforms 64.12% of its industry peers.
  • JBTM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.8%
PM (TTM) N/A
GM 35.15%
OM growth 3Y-13.13%
OM growth 5Y-10.64%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.82%
GM growth 5Y2.73%
JBTM Yearly Profit, Operating, Gross MarginsJBTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. JBTM Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so JBTM is destroying value.
  • Compared to 1 year ago, JBTM has more shares outstanding
  • JBTM has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for JBTM has been reduced compared to a year ago.
JBTM Yearly Shares OutstandingJBTM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
JBTM Yearly Total Debt VS Total AssetsJBTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • An Altman-Z score of 1.93 indicates that JBTM is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 1.93, JBTM is doing worse than 66.41% of the companies in the same industry.
  • JBTM has a debt to FCF ratio of 7.90. This is a slightly negative value and a sign of low solvency as JBTM would need 7.90 years to pay back of all of its debts.
  • JBTM has a Debt to FCF ratio of 7.90. This is comparable to the rest of the industry: JBTM outperforms 46.56% of its industry peers.
  • JBTM has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
  • JBTM's Debt to Equity ratio of 0.33 is fine compared to the rest of the industry. JBTM outperforms 62.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 7.9
Altman-Z 1.93
ROIC/WACC0.32
WACC9.39%
JBTM Yearly LT Debt VS Equity VS FCFJBTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 0.98 indicates that JBTM may have some problems paying its short term obligations.
  • The Current ratio of JBTM (0.98) is worse than 87.02% of its industry peers.
  • A Quick Ratio of 0.58 indicates that JBTM may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.58, JBTM is not doing good in the industry: 87.79% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.58
JBTM Yearly Current Assets VS Current LiabilitesJBTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. JBTM Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 25.10% over the past year.
  • JBTM shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.06% yearly.
  • The Revenue has grown by 121.34% in the past year. This is a very strong growth!
  • JBTM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.06% yearly.
EPS 1Y (TTM)25.1%
EPS 3Y10.26%
EPS 5Y10.06%
EPS Q2Q%16.47%
Revenue 1Y (TTM)121.34%
Revenue growth 3Y33.67%
Revenue growth 5Y17.06%
Sales Q2Q%115.57%

3.2 Future

  • The Earnings Per Share is expected to grow by 18.54% on average over the next years. This is quite good.
  • JBTM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.56% yearly.
EPS Next Y31.31%
EPS Next 2Y22.03%
EPS Next 3Y18.54%
EPS Next 5YN/A
Revenue Next Year6.73%
Revenue Next 2Y5.73%
Revenue Next 3Y5.56%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
JBTM Yearly Revenue VS EstimatesJBTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
JBTM Yearly EPS VS EstimatesJBTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. JBTM Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 20.32, which indicates a rather expensive current valuation of JBTM.
  • Based on the Price/Earnings ratio, JBTM is valued a bit cheaper than the industry average as 65.65% of the companies are valued more expensively.
  • JBTM is valuated rather cheaply when we compare the Price/Earnings ratio to 25.70, which is the current average of the S&P500 Index.
  • JBTM is valuated correctly with a Price/Forward Earnings ratio of 15.47.
  • 74.81% of the companies in the same industry are more expensive than JBTM, based on the Price/Forward Earnings ratio.
  • JBTM is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.84, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 20.32
Fwd PE 15.47
JBTM Price Earnings VS Forward Price EarningsJBTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • JBTM's Enterprise Value to EBITDA is on the same level as the industry average.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as JBTM.
Industry RankSector Rank
P/FCF 28.3
EV/EBITDA 17.98
JBTM Per share dataJBTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as JBTM's earnings are expected to grow with 18.54% in the coming years.
PEG (NY)0.65
PEG (5Y)2.02
EPS Next 2Y22.03%
EPS Next 3Y18.54%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. JBTM Dividend Analysis

5.1 Amount

  • JBTM has a yearly dividend return of 0.26%, which is pretty low.
  • JBTM's Dividend Yield is comparable with the industry average which is at 1.13.
  • With a Dividend Yield of 0.26, JBTM pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.26%

5.2 History

  • The dividend of JBTM has a limited annual growth rate of 4.31%.
  • JBTM has been paying a dividend for over 5 years, so it has already some track record.
  • JBTM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)4.31%
Div Incr Years0
Div Non Decr Years4
JBTM Yearly Dividends per shareJBTM Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 2026 0 0 0 0 0

5.3 Sustainability

  • The earnings of JBTM are negative and hence is the payout ratio. JBTM will probably not be able to sustain this dividend level.
  • JBTM's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-41.39%
EPS Next 2Y22.03%
EPS Next 3Y18.54%
JBTM Yearly Income VS Free CF VS DividendJBTM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

More info and screens

Find the best dividend stocksShow peers with best dividend

JBTM Fundamentals: All Metrics, Ratios and Statistics

JBT MAREL CORP

NYSE:JBTM (3/13/2026, 8:04:00 PM)

After market: 129.64 0 (0%)

129.64

-5.63 (-4.16%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-23
Earnings (Next)05-04
Inst Owners100.27%
Inst Owner ChangeN/A
Ins Owners0.72%
Ins Owner Change-1.34%
Market Cap6.74B
Revenue(TTM)3.80B
Net Income(TTM)-50.50M
Analysts83.33
Price Target159.94 (23.37%)
Short Float %4.99%
Short Ratio5.06
Dividend
Industry RankSector Rank
Dividend Yield 0.26%
Yearly Dividend0.5
Dividend Growth(5Y)4.31%
DP-41.39%
Div Incr Years0
Div Non Decr Years4
Ex-Date03-09
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.53%
Min EPS beat(2)0.65%
Max EPS beat(2)26.4%
EPS beat(4)4
Avg EPS beat(4)13.8%
Min EPS beat(4)0.65%
Max EPS beat(4)26.4%
EPS beat(8)5
Avg EPS beat(8)4.07%
EPS beat(12)9
Avg EPS beat(12)5.79%
EPS beat(16)12
Avg EPS beat(16)7.67%
Revenue beat(2)1
Avg Revenue beat(2)2.41%
Min Revenue beat(2)-0.3%
Max Revenue beat(2)5.11%
Revenue beat(4)3
Avg Revenue beat(4)1.77%
Min Revenue beat(4)-0.3%
Max Revenue beat(4)5.11%
Revenue beat(8)4
Avg Revenue beat(8)-1.3%
Revenue beat(12)4
Avg Revenue beat(12)-4.47%
Revenue beat(16)5
Avg Revenue beat(16)-3.58%
PT rev (1m)0%
PT rev (3m)3.98%
EPS NQ rev (1m)-2.18%
EPS NQ rev (3m)-1.97%
EPS NY rev (1m)6.27%
EPS NY rev (3m)6.32%
Revenue NQ rev (1m)2.1%
Revenue NQ rev (3m)2.21%
Revenue NY rev (1m)2.19%
Revenue NY rev (3m)2.27%
Valuation
Industry RankSector Rank
PE 20.32
Fwd PE 15.47
P/S 1.77
P/FCF 28.3
P/OCF 19.72
P/B 1.51
P/tB N/A
EV/EBITDA 17.98
EPS(TTM)6.38
EY4.92%
EPS(NY)8.38
Fwd EY6.46%
FCF(TTM)4.58
FCFY3.53%
OCF(TTM)6.57
OCFY5.07%
SpS73.08
BVpS85.89
TBVpS-20.91
PEG (NY)0.65
PEG (5Y)2.02
Graham Number111.04
Profitability
Industry RankSector Rank
ROA -0.62%
ROE -1.13%
ROCE 3.35%
ROIC 2.97%
ROICexc 3.05%
ROICexgc 22.87%
OM 5.8%
PM (TTM) N/A
GM 35.15%
FCFM 6.27%
ROA(3y)7.79%
ROA(5y)6.83%
ROE(3y)14.51%
ROE(5y)14.91%
ROIC(3y)4.56%
ROIC(5y)5.43%
ROICexc(3y)6.15%
ROICexc(5y)6.51%
ROICexgc(3y)26.08%
ROICexgc(5y)24.27%
ROCE(3y)5.13%
ROCE(5y)6.12%
ROICexgc growth 3Y6.06%
ROICexgc growth 5Y-7.67%
ROICexc growth 3Y-21.96%
ROICexc growth 5Y-23.95%
OM growth 3Y-13.13%
OM growth 5Y-10.64%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.82%
GM growth 5Y2.73%
F-Score3
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 7.9
Debt/EBITDA 3.02
Cap/Depr 38.92%
Cap/Sales 2.73%
Interest Coverage 250
Cash Conversion 70.25%
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.58
Altman-Z 1.93
F-Score3
WACC9.39%
ROIC/WACC0.32
Cap/Depr(3y)47.22%
Cap/Depr(5y)64.88%
Cap/Sales(3y)2.75%
Cap/Sales(5y)3.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.1%
EPS 3Y10.26%
EPS 5Y10.06%
EPS Q2Q%16.47%
EPS Next Y31.31%
EPS Next 2Y22.03%
EPS Next 3Y18.54%
EPS Next 5YN/A
Revenue 1Y (TTM)121.34%
Revenue growth 3Y33.67%
Revenue growth 5Y17.06%
Sales Q2Q%115.57%
Revenue Next Year6.73%
Revenue Next 2Y5.73%
Revenue Next 3Y5.56%
Revenue Next 5YN/A
EBIT growth 1Y83.81%
EBIT growth 3Y16.11%
EBIT growth 5Y4.61%
EBIT Next Year75.71%
EBIT Next 3Y29.74%
EBIT Next 5YN/A
FCF growth 1Y21.67%
FCF growth 3Y60.4%
FCF growth 5Y1.81%
OCF growth 1Y46.28%
OCF growth 3Y33.91%
OCF growth 5Y6.28%

JBT MAREL CORP / JBTM Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for JBT MAREL CORP?

ChartMill assigns a fundamental rating of 4 / 10 to JBTM.


What is the valuation status of JBT MAREL CORP (JBTM) stock?

ChartMill assigns a valuation rating of 5 / 10 to JBT MAREL CORP (JBTM). This can be considered as Fairly Valued.


How profitable is JBT MAREL CORP (JBTM) stock?

JBT MAREL CORP (JBTM) has a profitability rating of 3 / 10.


What is the financial health of JBT MAREL CORP (JBTM) stock?

The financial health rating of JBT MAREL CORP (JBTM) is 2 / 10.


How sustainable is the dividend of JBT MAREL CORP (JBTM) stock?

The dividend rating of JBT MAREL CORP (JBTM) is 3 / 10 and the dividend payout ratio is -41.39%.